3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
4
Multiple Myeloma
3
Glioma
3
Thyroid Neoplasms
2
Lymphoma
2
Hematologic Neoplasms
2
Glioblastoma
2
Astrocytoma
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Refractory Differentiated Thyroid Gland Carcinoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Neurofibromatosis 1
1
Neurofibroma, Plexiform
1
Neurocytoma
1
Neuroblastoma
1
Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Histiocytosis, Langerhans-Cell
1
Ganglioneuroma
1
Ganglioglioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Interventions
fludarabine
3
aldesleukin
3
Specimen Handling
3
Fluorouracil
3
Cyclophosphamide
3
Bevacizumab
3
Sunitinib
2
Leucovorin
2
trastuzumab deruxtecan
1
sodium propionate
1
semaglutide
1
repotrectinib
1
patritumab deruxtecan
1
isosorbide-5-mononitrate
1
fludarabine phosphate
1
dehydroftorafur
1
Ultrasonography
1
Tretinoin
1
Tomography, X-Ray Computed
1
Surveys and Questionnaires
1
Radiosurgery
1
Psilocybin
1
Positron-Emission Tomography
1
Photography
1
Pemetrexed
1
Pafolacianine
1
Oxaliplatin
1
Oviposition
1
Memantine
1
Magnetic Resonance Spectroscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastrointestinal Neoplasms
×
dabrafenib
×
30 days
×
Clear all
No trials found.